期刊文献+

紫杉醇联合醛氢叶酸、氟尿嘧啶及顺铂治疗晚期胃癌36例临床观察 被引量:2

下载PDF
导出
摘要 目的探讨紫杉醇(PTX)联合醛氢叶酸(CF)、氟尿嘧啶(5-Fu)、顺铂(DDP)治疗晚期胃癌的疗效及不良反应。方法本组36例病人均使用紫杉醇(PTX)120mg第1、8天静滴3h,CF 200mg静点2h,第1~5天,5-FU 750mg接CF后静点4h,第1~5天,顺铂(DDP)30mg静滴,第1~4天。两个周期以上,评定疗效、不良反应。结果完全缓解(CR)2例,部分缓解(PR)17例,SD12例,PD5例,总有效率52.8%;不良反应主要为I~Ⅱ度骨髓抑制、消化道反应、脱发。结论该方案治疗晚期胃癌可获得较高疗效,不良反应可耐受,是一种较好的联合化疗方案。
作者 李金运 于韬
出处 《齐齐哈尔医学院学报》 2008年第22期2712-2713,共2页 Journal of Qiqihar Medical University
  • 相关文献

参考文献6

  • 1Ajani JA. Chemotherapy for gastric carcinoma: new and old options[J]. Oncology(Huntingt),1998,12(10 Suppl 7) :44-47
  • 2Bleiberg H, Conroy T, PaiUot B, et al. Ramdomized phase Ⅱ studyof cisplatin and 5- Fu versus cisplatin alone in advanced spuamous cell esophageal cancer[J]. Eur J Cancer, 1997, 33: 1 216-1 220
  • 3秦叔逵,龚新雷.晚期胃癌化疗的现状和新进展[J].临床肿瘤学杂志,2006,11(9):641-652. 被引量:268
  • 4Ajani JA,Fairweather J,Dumas P,et al. Phase Ⅱ studyof Taxol in patients with advanced gastric carcinoma [J]. Cancer J Sci Am,1998,4(4) :269-274
  • 5Yamaguchi K,Tada M,Horikoshi N,et al. Phase Ⅱ studyof paclitaxel with 3 - h infusion in patients with advancedgastric cancer[J]. Gastric Cancer, 2002,5 (2) : 90-95
  • 6金懋林.胃癌内科化学治疗的新进展[J].医学临床研究,2003,20(10):735-738. 被引量:68

二级参考文献27

  • 1钱军,秦叔逵,梅静峰,陈映霞,邵志坚,何泽明.奥沙利铂联合卡培他滨二线治疗晚期胃癌的临床观察[J].中华肿瘤杂志,2004,26(12):746-748. 被引量:60
  • 2Sasaki T, Maeda Y, Kobayashi T, et al. Standard chemotherapy for gastrointestinal malignancies based on evidence[J]. Jap J Cancer Chemother , 2000,27(20):166-176.
  • 3Findlay M, Cunningham D, Norman A, et al . A phase Ⅱ study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF)[J]. Ann Oncol ,1994,5:609-616.
  • 4Cocconi G. Fluorouracil, doxorubicin,and mitomycin combination versus PELF chemotherapy in advanced gastric cancer:a prospective randomized trial of the Italian Oncology Group for Clinical Research[J]. J Clin Oncol ,1994,21(12) :2687.
  • 5Kim YH, Shin SW, Kim BS, et al . Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma[J]. Cancer , 1999,85:295-301.
  • 6Ajani J. Clinical update on an international phase Ⅱ/Ⅲ docetaxel trial(TAX 325)[J]. Proc Update Meeting on GIC ,2002.
  • 7Kim T, Ahn J,Lee J,et al . A phase Ⅱ trial of capecitabine( X )and cisplantin(P)in previously untreated advanced gastric cancer(AGC)[J]. Proc Am Soc Clin Oncol , 2001,20 : 166.
  • 8金懋林.抗癌新药治疗胃癌进展[A]..抗癌药物与肿瘤化学治疗进展[C].北京:科学出版社,2001.55—64.
  • 9Moiseyenko VM,Ajani JA,Tjulandin SA,et al.Final results of a randomized controlled phase Ⅲ trial (TAX 325) comparing docetaxel (T) combined with cisplatin (C) and 5-fluorouracil (F)to CF in patients (pts) with metastatic gastric adenocarcinoma (MGC)[ J ].J Clin Onc,Proc Am Soc Clin Oncol,2005,23:Abstract 4002.
  • 10Al-Batran S,Hartmann J,Probst S,et al.A randomized phase Ⅲ trial in patients with advanced adenocarcinoma of the stomach receiving first-line chemotherapy with fluorouracil,leucovorin and oxaliplatin (FLO) versus fluorouracil,leucovorin and cisplatin (FLP)[J].J Clin Onc,Proc Am Soc Clin Oncol,2006,24:Abstract 4016.

共引文献327

同被引文献15

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部